Biologics Boss: FDA Looking For Alternative Medical Device Sourcing Due To COVID-19
Executive Summary
Peter Marks, head of the US FDA’s biologics center, says the agency is looking for alternative sourcing and manufacturing of medical products imported from China, including medical devices, to ward off potential shortages that could result from the ongoing coronavirus crisis and containment.